Aquaporin: Induction and Role in Embryonic Ciliary Body
Principal Investigator
Jeanette Hyer, PhD
University of California, San Francisco
San Francisco, CA, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$70,000
Active Dates
April 01, 2004 - March 31, 2006
Grant ID
G2004038
Summary
A potential target of drug intervention for the treatment of glaucoma may be the aquaporin water channels found in the ciliary body of the eye. The ciliary body is the source of aqueous fluid. Aquaporins are membrane-channel proteins that are highly permeable to water, and aquaporin-1 and -4 are the major eye aquaporins expressed in the ciliary body. There is very little information on how these channels regulate their permeability to water. In previous research, Dr. Hyer demonstrated that Aquaporin-1 protein is expressed in the embryonic chick eye, which is an excellent model for eye development. She is now examining factors that lead to functional aquaporin water channels in the early development of the eye, and hopes to develop methods for reducing functional aquaporin channels in vivo. Once the requirements for aquaporin function in the eye have been determined, the chick embryo will then become a promising in-vivo model for testing the chemical and genetic interference with aquaporins.
Related Grants
National Glaucoma Research
Activating the Eye’s Own Nitric Oxide to Fight Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Myoungsup Sim, PhD
Current Organization
Duke University School of Medicine
Activating the Eye’s Own Nitric Oxide to Fight Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Myoungsup Sim, PhD
Current Organization
Duke University School of Medicine
National Glaucoma Research
Spatial Responses to Elevated Pressure in the Human Optic Nerve Head
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Jeremy Sivak, PhD
Current Organization
University Health Network
Spatial Responses to Elevated Pressure in the Human Optic Nerve Head
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Jeremy Sivak, PhD
Current Organization
University Health Network
National Glaucoma Research
Foot-Based Monitoring and Feedback to Improve Mobility and Reduce Falls in Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Navid Amini, PhD
Current Organization
California State University, Los Angeles
Foot-Based Monitoring and Feedback to Improve Mobility and Reduce Falls in Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Navid Amini, PhD
Current Organization
California State University, Los Angeles